(Press-News.org) A medication commonly used to help people stop smoking may have an unanticipated positive side effect for an entirely different vice: drinking alcohol. A new study by University of Chicago researchers finds that varenicline, sold as Chantix, increases the negative effects of alcohol and therefore could hold promise as a treatment for alcoholism.
A group of heavy-to-moderate social drinkers given a single dose varenicline three hours before an alcoholic beverage reported increased dysphoria and reduced "liking," even when researchers controlled for the effects of nausea from the drug. Those effects upon the subjective response to alcohol could reduce drinking in people prone to bingeing and other forms of abuse.
"We found that varenicline increased the unpleasant effects of alcohol and decreased drug liking," said Emma Childs, PhD, research associate at the University of Chicago Medicine and first author of the study published in Alcoholism: Clinical and Experimental Research. "Thus, we think that varenicline may reduce drinking by altering the effects of alcohol."
Some patients prescribed Chantix to quit smoking have anecdotally reported a reduction in consumption of alcohol as well, and controlled studies in animals and humans have supported the effect. Researchers are now looking for neurobiological mechanisms that connect varenicline, a partial agonist of the brain's nicotinic receptors, with reduced alcohol craving or consumption.
"Smokers who use varenicline are approximately two to three times more likely to remain abstinent six months or more after their quit date," said Childs. "After it was approved, several patients treated with varenicline also reported reductions in their drinking, so investigators began to assess if this was an actual effect and how it might be produced."
The new experiment is the first to look at the acute effects of a single dose of varenicline on the subjective response to a subsequent alcoholic drink. Subjects were recruited based on heavy drinking behavior, not smoking behavior – though the recruits did smoke 4 cigarettes a day on average.
15 subjects (8 men and 7 women) were brought to the laboratory for six different sessions. On each day, the subject received either a varenicline or placebo capsule, and then three hours later was given a drink containing 0, 0.4, or 0.8 mg/kg alcohol. Researchers monitored the effects of the drink on cardiovascular and eye movement measures, and subjects filled out questionnaires to report the subjective effects of the drink.
Compared to sessions where the subjects received a placebo pill, varenicline increased nausea, heart rate, blood pressure. After an alcoholic drink, self-reported dysphoria was increased while alcohol effects on subconscious eye movements (a measure of the drugs' objective effects) were reduced. Even after controlling for the effect of nausea upon the subsequent response to a drink, the increased dysphoria and reduced "drug liking" after drinking alcohol remained significant.
By increasing the negative effects of alcohol, varenicline might be most effective in people who are unable to stop consuming alcohol after only one drink, Childs said.
"Our findings shed light on the mechanism underlying why people consume less alcohol when they have taken varenicline," said Childs. "The pleasurable effects of alcohol, for example feeling 'buzzed' and talkative, are associated with greater consumption and binge drinking. Some people lose control of their alcohol consumption during a drinking episode, for example they may aim to only have one or two drinks but end up drinking say four or five. If varenicline counteracts these positive effects by producing unpleasant effects, then as a result people may consume less alcohol during a drinking episode."
The authors cautioned that their study only examined the acute effect of a single dose of varenicline, rather than the sustained exposure experienced with regular use of the drug. But because the effectiveness of varenicline has already been proven as a smoking cessation drug, the unanticipated effects on drinking may make people struggling with both behaviors a logical first target.
"Varenicline may find a nice niche in those individuals who are both nicotine and alcohol dependent, who we know represent a large portion of alcohol-dependent individuals," added Hugh Myrick, associate professor of psychiatry at the Medical University of South Carolina, who was not involved in the study. "Since there is a high comorbidity between nicotine and alcohol dependence, a single medication that could decrease the use of both substances would be ideal."
###
The paper, "Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements," will be published online by Alcoholism: Clinical and Experimental Research on February 15th. In addition to Childs, authors include Daniel J. O. Roche, Andrea C. King, and Harriet de Wit of the University of Chicago Medicine.
Funding for the research was provided by the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism.
Journalists: A full copy of the manuscript may be obtained by contacting Mary Newcomb with the ACER Editorial Office at AcerJournal@earthlink.net
For more news from the University of Chicago Medicine, follow us on Twitter at @UChicagoMed, or visit our Facebook page at facebook.com/UChicagoMed, our research blog at sciencelife.uchospitals.edu, or our newsroom at uchospitals.edu/news.
END
A team led by a University of British Columbia professor has developed a new class of drugs that completely suppress absence seizures – a brief, sudden loss of consciousness – in rats, and which are now being tested in humans.
Absence seizures, also known as "petit mal seizures," are a symptom of epilepsy, most commonly experienced by children. During such episodes, the person looks awake but dazed. The seizures, arising from a flurry of high-frequency signals put out by the neurons of the thalamus, can be dangerous if they occur while a person is swimming or driving, ...
The ability to change vocal sounds (vocal plasticity) and develop an accent is potentially far more widespread in mammals than previously believed, according to new research on goats from Queen Mary, University of London.
Vocal plasticity is the ability of an individual to modify the sound of their voice according to their social environment. Humans benefit from an extreme form of vocal plasticity which allows us to produce a wide range of sounds and accents, but in most other mammals (except, for example, bats and whales) vocalisations were thought to be genetically ...
The study of more than 11,000 pregnant women, in partnership with Mars Petcare, showed that those who owned dogs were approximately 50% more likely to achieve the recommended 30 minutes of exercise a day through high levels of brisk walking than those without dogs. Scientists suggest that as it is a low-risk exercise, walking a dog could form part of a broader strategy to improve the health of pregnant women.
Previous studies have shown that maternal obesity and large weight gain during pregnancy has adverse outcomes for mother and child. Studies show, for example, that ...
CINCINNATI -- As part of the first national, randomized clinical trial to study two methods of drug delivery for seizing patients, researchers have shown that using an auto-injector, similar to an EpiPen, to deliver anticonvulsant medication stops prolonged seizures more quickly and effectively than drug delivery through an IV line.
The research, which will be published in the Feb. 16 edition of the New England Journal of Medicine, was conducted as part of the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART), which included University of Cincinnati (UC) ...
VTT Technical Research Centre of Finland, the leading multi-technological applied research organisation in Northern Europe, has developed an optical accessory that turns an ordinary camera phone into a high-resolution microscope. The device is accurate to one hundredth of a millimetre. Among those who will benefit from the device are the printing industry, consumers, the security business, and even health care professionals. A new Finnish enterprise called KeepLoop Oy and VTT are already exploring the commercial potential of the invention. The first industrial applications ...
BOSTON, MA (February 15, 2012) — For decades, researchers have sought a genetic explanation for idiopathic dilated cardiomyopathy (DCM), a weakening and enlargement of the heart that puts an estimated 1.6 million Americans at risk of heart failure each year. Because idiopathic DCM occurs as a familial disorder, researchers have long searched for genetic causes, but for most patients the etiology for their heart disease remained unknown.
Now, new work from the lab of Christine Seidman, a Howard Hughes Investigator and the Thomas W. Smith Professor of Medicine and Genetics ...
When a person is experiencing a prolonged convulsive seizure, quick medical intervention is critical. With every passing minute, the seizure becomes harder to stop, and can place the patient at risk of brain damage and death. This is why paramedics are trained to administer anticonvulsive medications as soon as possible -- traditionally giving them intravenously before arriving at the hospital.
Now a major clinical trial has shown that an even faster method that involves injecting the drugs into the thigh muscle using an autoinjector (similar to a pre-loaded syringe) ...
Like a stream of air shooting out of an airplane's broken window to relieve cabin pressure, scientists at Scripps Institution of Oceanography at UC San Diego say lava formations in eastern Oregon are the result of an outpouring of magma forced out of a breach in a massive slab of Earth. Their new mechanism explaining how such a large volume of magma was generated is published in the Feb. 16 issue of the journal Nature.
For years scientists who study the processes underlying the planet's shifting tectonic plates and how they shape the planet have debated the origins of ...
Astronomers using NASA's Hubble Space Telescope have found a cluster of young, blue stars encircling the first intermediate-mass black hole ever discovered. The presence of the star cluster suggests that the black hole was once at the core of a now-disintegrated dwarf galaxy. The discovery of the black hole and the star cluster has important implications for understanding the evolution of supermassive black holes and galaxies.
"For the first time, we have evidence on the environment, and thus the origin, of this middle-weight black hole," said Mathieu Servillat, who worked ...
VIDEO:
An argon plasma jet forms a rapidly growing corkscrew, known as a kink instability. This instability causes an even faster-developing behavior called a Rayleigh-Taylor instability, in which ripples grow and...
Click here for more information.
PASADENA, Calif.—January saw the biggest solar storm since 2005, generating some of the most dazzling northern lights in recent memory.
The source of that storm—and others like it—was the sun's magnetic field, described by ...
